0001127602-11-008732.txt : 20110303
0001127602-11-008732.hdr.sgml : 20110303
20110303160948
ACCESSION NUMBER: 0001127602-11-008732
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110301
FILED AS OF DATE: 20110303
DATE AS OF CHANGE: 20110303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MOHAPATRA SURYA N
CENTRAL INDEX KEY: 0001222671
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 11660337
MAIL ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
4
1
form4.xml
PRIMARY DOCUMENT
X0303
4
2011-03-01
0001022079
QUEST DIAGNOSTICS INC
DGX
0001222671
MOHAPATRA SURYA N
C/O QUEST DIAGNOSTICS INCORPORATED
3 GIRALDA FARMS
MADISON
NJ
07940
1
1
Chairman, President & CEO
Common Stock
2011-03-01
4
M
0
20555
48.74
A
388527
D
Common Stock
2011-03-01
4
S
0
20555
56.7519
D
367972
D
Common Stock
5166
I
401(k)/sdcp
Stock Options (Right to Buy)
48.74
2011-03-01
4
M
0
20555
0
D
2012-02-22
Common Stock
20555
226111
D
This transaction was executed in multiple trades at prices ranging from $56.62 to $56.9562. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a recent date. The number of shares is based on the account balance of the Company stock fund under the plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
The options vested in three installments beginning with the first on February 22, 2006, the second on February 22, 2007 and the final on February 22, 2008.
This exercise and sale reported were effected pursuant to Rule 10b-5-1 sales plan adopted by the reporting person on February 15, 2011.
/s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Surya N. Mohapatra
2011-03-02